109 related articles for article (PubMed ID: 25987065)
1. Aberrant Expression of HOXA5 and HOXA9 in AML.
Zhao P; Tan L; Ruan J; Wei XP; Zheng Y; Zheng LX; Jiang WQ; Fang WJ
Asian Pac J Cancer Prev; 2015; 16(9):3941-4. PubMed ID: 25987065
[TBL] [Abstract][Full Text] [Related]
2. [Expression of HOXB4, PRDM16 and HOXA9 in Patients with Acute Myeloid Leukemia and Its Clinical Significance].
Li L; Zhao CT; Cui BL; Wu SL; Liu XD; Su Z; Yang J; Wang W; Cui ZG; Zhao HG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):326-31. PubMed ID: 27150986
[TBL] [Abstract][Full Text] [Related]
3. HOXA9 gene expression in acute myeloid leukemia.
Li DP; Li ZY; Sang W; Cheng H; Pan XY; Xu KL
Cell Biochem Biophys; 2013; 67(3):935-8. PubMed ID: 23575938
[TBL] [Abstract][Full Text] [Related]
4. [Expression of homeobox gene HOXA9 in childhood acute leukemia, and its clinical significance].
Jia XH; Zhu LP; Li JC; Wang CC
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Apr; 15(4):268-72. PubMed ID: 23607948
[TBL] [Abstract][Full Text] [Related]
5. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA
Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874
[TBL] [Abstract][Full Text] [Related]
6. High expression of HOXA5 is associated with poor prognosis in acute myeloid leukemia.
Yang Y; Zhong F; Huang X; Zhang N; Du J; Long Z; Zheng B; Lin W; Liu W; Ma W
Curr Probl Cancer; 2021 Jun; 45(3):100673. PubMed ID: 33223227
[TBL] [Abstract][Full Text] [Related]
7. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
[TBL] [Abstract][Full Text] [Related]
8. Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia.
Drabkin HA; Parsy C; Ferguson K; Guilhot F; Lacotte L; Roy L; Zeng C; Baron A; Hunger SP; Varella-Garcia M; Gemmill R; Brizard F; Brizard A; Roche J
Leukemia; 2002 Feb; 16(2):186-95. PubMed ID: 11840284
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of HOXA9, DEK, CBL and CSF1R in acute myeloid leukemia.
Casas S; Nagy B; Elonen E; Aventín A; Larramendy ML; Sierra J; Ruutu T; Knuutila S
Leuk Lymphoma; 2003 Nov; 44(11):1935-41. PubMed ID: 14738146
[TBL] [Abstract][Full Text] [Related]
10. Level of HOXA5 hypermethylation in acute myeloid leukemia is associated with short-term outcome.
Kim SY; Hwang SH; Song EJ; Shin HJ; Jung JS; Lee EY
Korean J Lab Med; 2010 Oct; 30(5):469-73. PubMed ID: 20890077
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor AP-2α regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression.
Ding X; Yang Z; Zhou F; Wang F; Li X; Chen C; Li X; Hu X; Xiang S; Zhang J
Int J Biochem Cell Biol; 2013 Aug; 45(8):1647-56. PubMed ID: 23660297
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of homeobox A5 by small hairpin RNA inhibits proliferation and enhances cytarabine chemosensitivity of acute myeloid leukemia cells.
Li N; Jia X; Wang J; Li Y; Xie S
Mol Med Rep; 2015 Nov; 12(5):6861-6. PubMed ID: 26397212
[TBL] [Abstract][Full Text] [Related]
13. Homeobox
Badr E; El-Sayed IT; Alasadi M
Br J Biomed Sci; 2021 Jul; 78(3):117-121. PubMed ID: 33461426
[No Abstract] [Full Text] [Related]
14. PARP-1 Overexpression as an Independent Prognostic Factor in Adult Non-M3 Acute Myeloid Leukemia.
Pashaiefar H; Yaghmaie M; Tavakkoly-Bazzaz J; Ghaffari SH; Alimoghaddam K; Momeny M; Izadi P; Izadifard M; Kasaeian A; Ghavamzadeh A
Genet Test Mol Biomarkers; 2018 Jun; 22(6):343-349. PubMed ID: 29812960
[TBL] [Abstract][Full Text] [Related]
15. Expression profiling of cancer-related galectins in acute myeloid leukemia.
El Leithy AA; Helwa R; Assem MM; Hassan NH
Tumour Biol; 2015 Sep; 36(10):7929-39. PubMed ID: 25953264
[TBL] [Abstract][Full Text] [Related]
16. Expression of Eph A4, Eph B2 and Eph B4 receptors in AML.
Wrobel T; Pogrzeba J; Stefanko E; Wojtowicz M; Jazwiec B; Dzietczenia J; Mazur G; Kuliczkowski K
Pathol Oncol Res; 2014 Oct; 20(4):901-7. PubMed ID: 24764074
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of FLT3 gene expression level and internal tandem duplication mutation in acute myeloid leukemia and its clinical significance].
Wang YG; Liu XH; Liang Y; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):741-5. PubMed ID: 19176010
[TBL] [Abstract][Full Text] [Related]
18. Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Chaudhary AK; Chaudhary S; Ghosh K; Shanmukaiah C; Nadkarni AH
Asian Pac J Cancer Prev; 2016; 17(3):1519-29. PubMed ID: 27039800
[TBL] [Abstract][Full Text] [Related]
19. WT1 Expression in Adult Acute Myeloid Leukemia: Assessing its Presence, Magnitude and Temporal Changes as Prognostic Factors.
Ujj Z; Buglyó G; Udvardy M; Beyer D; Vargha G; Biró S; Rejtő L
Pathol Oncol Res; 2016 Jan; 22(1):217-21. PubMed ID: 26531831
[TBL] [Abstract][Full Text] [Related]
20. [Effect of Knocking Out
Man JC; Cheng J; Zhao L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):52-56. PubMed ID: 38387899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
